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Upper lipThe upper lip and primary palate form an essential separation between the brain, nasal structures and the
oral cavity. Surprisingly little is known about the development of these structures, despite the fact that ab-
normalities can result in various forms of orofacial clefts. We have uncovered that retinoic acid is a critical
regulator of upper lip and primary palate development in Xenopus laevis. Retinoic acid synthesis enzyme,
RALDH2, and retinoic acid receptor gamma (RARγ) are expressed in complementary and partially overlapping
regions of the orofacial prominences that fate mapping revealed contribute to the upper lip and primary pal-
ate. Decreased RALDH2 and RARγ result in a median cleft in the upper lip and primary palate. To further un-
derstand how retinoic acid regulates upper lip and palate morphogenesis we searched for genes
downregulated in response to RARγ inhibition in orofacial tissue, and uncovered homeobox genes lhx8 and
msx2. These genes are both expressed in overlapping domains with RARγ, and together their loss of function
also results in a median cleft in the upper lip and primary palate. Inhibition of RARγ and decreased Lhx8/Msx2
function result in decreased cell proliferation and failure of dorsal anterior cartilages to form. These results
suggest a model whereby retinoic acid signaling regulates Lhx8 and Msx2, which together direct the tissue
growth and differentiation necessary for the upper lip and primary palate morphogenesis. This work has
the potential to better understand the complex nature of the upper lip and primary palate development
which will lead to important insights into the etiology of human orofacial clefts.
Published by Elsevier Inc.Introduction
The human orofacial region is incredibly important, as it not only
serves as our gateway to the environment, but also permits ingestion,
taste, communication and facial recognition. It is not surprising, then,
that birth defects affecting the mouth and face are among the most
devastating. Indeed, the most common of all birth defects are clefts
in the lip and palate-occurring in approximately 1 in 1000 children
annually (Research, 2011). Despite this, the mechanisms that cause
orofacial clefts are still not completely understood, likely due to
their multifactorial nature and the difﬁculty of in vivo studies in
mammalian models. We have turned to the frog, Xenopus, to gain bet-
ter insight into the etiology of facial clefts. The conserved orofacial re-
gion is easily accessible through all stages of development, thereby
offering an array of molecular and embryological approaches to
study the complex developmental events of orofacial development.
The orofacial region develops from seven facial prominences: the
singular frontonasal and paired lateral nasal, maxillary and mandibu-
lar prominences. These prominences grow and converge to surround
the embryonic mouth (for reviews see Jugessur et al., 2009; Liu et al.,n).
nc.2010; Tapadia et al., 2005). Fusion of the maxillary and nasal promi-
nences with the frontonasal prominence dorsal to the mouth opening
forms the upper lip and primary palate (Greene and Pisano, 2010;
Jiang et al., 2006; Meng et al., 2009). Later, bilateral outgrowths
from the maxillary prominence fuse to form the secondary palate, a
specialized characteristic of amniotes. The primary and secondary
palates, as well as the upper lip, create an important separation be-
tween the oral opening and nasal passage. Much attention has been
paid to the development of the secondary palate, since defects in its
formation are attributed to many forms of cleft palate in humans.
However, less is known about the development of the upper lip and
primary palate despite the fact that defects in these structures also re-
sult in several forms of cleft lip and palate, and may be an underlying
cause of many forms of secondary cleft palate (Greene and Pisano,
2010; Jiang et al., 2006; Meng et al., 2009).
Proper development of the palate and upper lip requires interac-
tions between neural crest, forebrain, ectoderm mesoderm and pha-
ryngeal endoderm (Couly et al., 2002; Hu and Helms, 1999; Ruhin
et al., 2003). Precise cell growth, migration, fusion and apoptosis are
also necessary for the formation of this region. Therefore, it follows
that the development of the orofacial structure involves a complex
network of transcription factors and signaling pathways (Brugmann
et al., 2006; Greene and Pisano, 2010). The critical signaling molecule,
retinoic acid, has numerous endogenous roles in the development of
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(reviewed in Mark et al., 2004). Retinaldehyde is oxidized into reti-
noic acid by retinol dehydrogenases (RALDH), thereby allowing it to
diffuse into neighboring cells, bind to RXR and RAR nuclear receptors,
and activate transcription (Duester, 2008). Misregulation of retinoic
acid signaling has been associated with orofacial clefts in mammals.
For example, mice deﬁcient in members of the RALDH or RAR gene
families exhibit craniofacial defects, including cleft lip (Dupe and
Pellerin, 2009; Halilagic et al., 2007). Additionally, an excess of reti-
noic acid – such as Accutane exposure during pregnancy – has been
correlated with cleft lip and palate in humans and animal models
(Malvasi et al., 2009; Vieux-Rochas et al., 2007). Together, these
studies suggest that normal orofacial development requires precise
regulation of the retinoic acid signaling gradient.
How misregulation of retinoic acid signaling results in orofacial
clefts is not completely clear. Canonical retinoic acid signaling acti-
vates transcription, and it is therefore predicted to be necessary for
activation of one or more genes that regulate orofacial morphogene-
sis. Some of the most well studied genes activated transcriptionally
by retinoic acid signaling are those belonging to the Homeobox
gene family (Glover et al., 2006). Members of this family are tran-
scription factors characterized by the presence of a well conserved
DNA binding domain called the homeodomain. In addition to the
homeodomain, some homeobox genes also have other domains (such
as LIM, POU and paired domains) that provide an additional level of
DNA binding speciﬁcity (Foronda et al., 2009). While much is known
about how retinoic acid regulates homeobox genes in the brain
(Glover et al., 2006), little is known about this interaction in the facial
region. Several homeobox genes are expressed in the orofacial region
including msx (muscle segment homeobox) and lhx (lim homeobox)
gene family members (Alappat et al., 2003; Washbourne and Cox,
2006; Zhadanov et al., 1995; Zhang et al., 2002). Further, misregulation
of such homeobox genes has been shown to result in orofacial clefts in
mice, and has been correlated with cases of cleft palate in humans
(Satokata and Maas, 1994; Zhao et al., 1999).
In the current study, we show that retinoic acid does in fact regu-
late expression of the homeobox genes msx2 and lhx8 in the orofacial
region. Misregulation of retinoic acid and loss of these homeobox
genes both result in failure of the dorso-anterior facial prominences
to undergo growth and convergence resulting in a speciﬁc type of
cleft — a median facial cleft (Allam et al., 2011). Further, the cartilage
elements associated with the upper lip and primary palate are either
missing or malformed. We show that this phenotype may in part be
due to a disruption in cell proliferation and differentiation. These re-
sults suggest a novel role for retinoic acid in the regulation of cranio-
facial development in directing the development of the upper lip and
primary palate.
Materials and methods
Embryos
Xenopus laevis embryos were obtained and cultured using stan-
dard methods (Sive et al., 2000). Embryos were staged according to
Nieuwkoop and Faber (Nieuwkoop and Faber, 1967).
In situ hybridization
In situ hybridizations were performed on isolated heads as de-
scribed (Sive et al., 2000), omitting the proteinase K treatment.
cDNAs used to transcribe in situ hybridization probes were RALDH2
(AF310252.1, from Openbiosystems, MXL1736-99822041), RARγ
(BC071082.1, from Openbiosystems, MXL1736-9507435), AP-2
(Winning et al., 1991), lhx8 (BC057730, from Openbiosystems,
MXL1736-8950926), and msx2 (CA792675.1, from Openbiosystems,
EXL1051-5637033).Morpholinos and transplants
Antisense morpholinos were purchased from Genetools. RALDH2
morpholino was designed and validated by Strate et al. (2009),
msx2 splice blocking morpholino was designed and validated by
Khadka et al. (2006) and a translation blocking lhx8 morpholino
was designed by Genetools (sequence available upon request). A
standard control morpholino was used as a control in all experiments.
Transplants from morphants to uninjected siblings and vice versa
were performed as described (Dickinson and Sive, 2009). Rescue
of the RALDH2 morpholino was performed in a matched experi-
ment where 10 embryos (st. 24) that were injected with ﬂuorescently
labeled RALDH2 morpholino were chosen with identical ﬂuorescence
(intensity and location) and phenotype. Half of these identical em-
bryos were treated with 5 μM ATRA and half were treated with carrier
(ethanol). The same procedure was performed with embryos injected
with control morpholino. lhx8 ORF was cloned into pCS2+ plasmid
and RNA in vitro transcribed using the mMessage Machine kit
(Ambion) to use for lhx8 morpholino rescue experiments.Chemical treatments
Stock solutions were RAR inhibitor (BMS-453, Tocris (3409),
10 mM in DMSO), RALDH2 inhibitor (citral, Fluka (27450)), wee-1
inhibitor (PD-407824 Sigma (PZ0111), 10 mM stock in DMSO), all-
trans retinoic acid (Sigma (R2625), 10 mM stock in DMSO), hy-
droxyurea (sigma (H8627), 500 mM stock in water), and aphidicolin
(sigma (A0781) 15 mM stock in DMSO). Embryos were bathed in in-
hibitor solutions combined with 1% DMSO in 0.1% MBS (modiﬁed
Barth's saline, pH 7.8) in culture dishes.Immunohistochemistry and phalloidin staining
Specimens were embedded in 4% low-melt agarose (SeaPlaque
GTG, Cambrex) and sectioned with a 5000 Series Vibratome at 75–
100 μm. Immunohistochemistry was performed as described
(Dickinson and Sive, 2006) using a polyclonal anti-ph3 antibody
(Millipore, 06-570, diluted 1:1000), rabbit anti-cleaved caspase-3
(Cell Signalling, 9661S, diluted 1:1000) or mouse anti-collagen II
(DSHB, II-II6B3, diluted 1:100). Appropriate secondary AlexaFluor
488 antibodies (Invitrogen) were diluted 1:500. Counterstains in-
cluded 0.1% propidium iodide (Sigma, P4864) or Phalloidin (Invitro-
gen, A12379).Fate mapping
Fate mapping was performed as described previously (Dickinson
and Sive, 2006). Brieﬂy a 25–50 nl drop of 1,1-dioctadecyl-3,3,3,3-
tetramethylindocarbocyanin (CM-DiI; 2 mg/ml, Molecular Probes)
using an Eppendorf micro-pressure injector and a glass pulled capil-
lary tube was placed just below the surface of the outer ectodermal
cells. Embryos were ﬁxed and labeled with phalloidin as described
above.Alcian blue staining
Cartilages were stained using standard protocols with some mod-
iﬁcations (Taylor and Van Dyke, 1985). Brieﬂy, tadpoles were ﬁxed in
Bouin's ﬁxative overnight at 4 °C and then washed in 70% ethanol.
They were then immersed in Alcian blue stain; (0.1 mg/ml Alcian
blue in 1 part acetic acid:4 parts ethanol) for 3–4 days at RT. Embryos
were washed in 1% HCL in 70% ethanol for 1–2 days and cleared in 2%
potassium hydroxide and glycerol.
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Tissue was collected from the orofacial region of the embryo at
stage 30 (35 hpf) at the end of RAR inhibitor or control treatment.
One hundred ﬁfty dissections were performed for each treatment
and stored in Trizol (Invitrogen) at−80 °C. RNA preparation and mi-
croarray hybridization were performed as described previously
(Dickinson and Sive, 2009) in collaboration with Dr. Myrna Serrano
at the VCU NARF core facility. For RT-PCR, total RNA was isolated
using Trizol extraction followed by a lithium chloride solution
(Ambion) precipitation. cDNA was prepared using the Omniscript
Kit (Qiagen) and standard PCR was performed using Apex Hotstart
Mastermix. Primer sequences are available upon request.Results
Early development of the upper lip and primary palate
The formation of the upper lip and primary palate has not yet been
examined using modern techniques in the frog. Here, we present
some of the ﬁrst descriptions of orofacial morphogenesis in X. laevis.
At stages 32–35 (35 hpf) the bilaterally symmetrical ﬁrst branchi-
al or pharyngeal arch ﬂanks each side of the stomodeum (Dickinson
and Sive, 2006) (Fig. 1A,B). Transverse sections through the orofacial
region during this time indicate that the epithelial lined oral cavity, as
identiﬁed by e-cadherin immunohistochemistry, is directly juxta-
posed with the brain (Fig. 1B). By stage 35, the facial prominences
can subtly be distinguished from one another in whole embryo and
in transverse sections. Dorsal to the stomodeum is the singular fron-
tonasal prominence and the bilaterally symmetrical medial nasal
prominences located just below the nasal placodes (Fig. 1C,D). Lateral
to the stomodeum, the ﬁrst pharyngeal arch is subdivided into the
dorsal maxillary and ventral mandibular prominences (Fig. 1C,D). At
stage 39, the stomodeum deepens (Fig. 1E) and the mesenchyme of
the maxillary and medial nasal prominences converges dorsally
(Fig. 1F). By stages 40 and 41 (66–76 hpf), the perforation of the
mouth is complete and the foregut connects to the external environ-
ment (Fig. 1G,I). Also at this time, mesenchymal cells move into the
region separating the brain and the oral cavity (Fig. 1H,J). As develop-
ment proceeds, the tissue between the oral epithelium and brain
thickens to eventually form the upper lip and primary palate.
Here, we have deﬁned 40–66 hpf as the time when the region
forming the upper lip and primary palate begins to morphologically
develop. Our next goal was to determine how the initial development
of this region is regulated, speciﬁcally by retinoic acid signaling.Fig. 1. Facial development in Xenopus laevis from stages 32–41 (40–76 hpf). A, C, E, G, I) Fron
or embryonic mouth (outlined in red dots). B, D, F, H, J) Transverse sections through the facia
phalloidin (which labels F-actin, green). Abbreviations: BA1; 1st branchial arch, cg; cemen
prominence, np; nasal placode or pit.RALDH2 and RARγ are expressed in complementary and overlapping
regions of the maxillary and nasal prominences
We ﬁrst needed to determine which retinoic acid signaling com-
ponents are expressed in the orofacial region in Xenopus just preced-
ing the initial development of the upper lip and primary palate. We
chose a speciﬁc developmental window, from stages 24 to 30 (26–
35 hpf), when the craniofacial prominences are being speciﬁed and
the neural crest has already migrated into the region. Two retinoic
acid pathway members, RALDH2 and retinoic acid receptor gamma
(RARγ), were uncovered in a microarray expression screen for
genes enriched in the embryonic mouth and surrounding tissue
(Dickinson and Sive, 2009 and unpublished). Xenbase expression da-
tabase and published reports support this data (Bowes et al., 2011;
Lynch et al., 2011). Expression of other RALDH genes (RALDH1 and
RALDH3) is conﬁned to the eye at the stages we were interested in
(Lynch et al., 2011). Further, other retinoic acid receptors (RARβ and
RARα) are not expressed in the orofacial region during the speciﬁed
time frame (Escriva et al., 2006; Shiotsugu et al., 2004). Therefore,
we focused on RARγ and RALDH2 expressions as likely effectors of
retinoic acid signaling in the upper lip and primary palate.
In situ hybridizations indicate that RALDH2 expression during
stages 24–30 is localized in the embryonic mouth anlage and a re-
gion corresponding to the medial and lateral nasal prominences
bordering the frontonasal prominence (see representative stages
24 and 28, Fig. 2A,C). RARγ is expressed in the future facial tissue
corresponding to the ﬁrst pharyngeal arch, as well as the medial
nasal prominences at stage 24. Later at stage 28, it becomes reﬁned
in the paired maxillary and medial nasal prominences (Fig. 2C,B).
This RARγ expression domain directly borders and overlaps with
the RALDH2 expression domain. To determine if RARγ was ex-
pressed in neural crest cells, we performed side by side in situ hy-
bridizations with the neural crest marker, AP-2, and found that the
RARγ expression pattern partly overlaps with this gene (Fig. 2E,F).
This result suggests the possibility that RARγ is expressed in neural
crest cells, as well as the adjacent mesoderm.
We next asked whether the RARγ expressing tissue in the maxil-
lary and medial nasal prominences contributes to the upper lip and
primary palate area. The lipophilic dye, DiI, was injected dorsolater-
ally to the stomodeum (Fig. 2G) corresponding to the RARγ expres-
sion domain at stages 28–30. Later, at stages 41–42, embryos were
sectioned and counter labeled with phalloidin to provide context.
The tissue located at the midline overlying the oral ectoderm was la-
beled with DiI in 90% of the embryos (Fig. 2H; n=10). These results
suggest that the RARγ expression region does indeed contribute to
the upper lip and primary palate region dorsal to the mouth.tal views of tadpole faces. The arrow points to the stomodeum (outlined in yellow dots)
l prominences. E-cadherin labels epithelium (red), and all tissue is counterstained with
t gland, mx; maxillary prominence, mnp; medial nasal prominence, ma; mandibular
Fig. 2. A–D) frontal views of tadpole faces showing whole mount in situ hybridizations of RALDH2 (A,C) and RARγ (B,D) mRNA expression. The cement gland (cg) is pseudo-colored
brown. The arrow points to the stomodeum. E,F) Transverse sections of RARγmRNA expression and neural crest marker AP-2 in the orofacial region. G,H) DiI (red) fate mapping and
phalloidin counterstaining labeling all F-actin (green). G) A frontal view of a tadpole ﬁxed immediately post labeling with DiI in the RARγ expression domain at stage 28 (corre-
sponding to panel D). The arrow points to the stomodeum. H) DiI labeling in transverse section approximately 40 h post labeling. DiI is observed in the primary palate region dorsal
to the oral cavity. Abbreviations: cg; cement.
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retinoic acid signals emanate from the mouth anlage and nasal
prominences, and are received by RARγ receptors in neural crest
and/or mesenchymal cells in the developing maxillary and medial
nasal prominences (see model Fig. 9). Such expression patterns
and fate mapping results suggest that retinoic acid signaling may
be integral to the formation of the primary palate and associated fa-
cial elements. Therefore, we tested this hypothesis using loss of
function approaches.Decreased RALDH2 results in an abnormal shape of the developing
mouth, resembling a median orofacial cleft
We performed loss of function of the RA synthesizing enzyme,
RALDH2, using translation blocking Morpholino stabilized antisense
oligos (Morpholino (MO), Genetools) injected into one-cell stage
embryos (Fig. 3A) (Strate et al., 2009). A standard control morpho-
lino (CMO) from Genetools was used as a control. RALDH2 mor-
phant embryos had various defects such as a narrower face,
abnormal eyes and hyper-pigmentation (Fig. 3B,C). Importantly, ab-
normal triangular shapes of the embryonic mouth were noted, in-
cluding a dorsal median cleft, in approximately 40% of the
RALDH2 morphants when compared to CMO injected (n=90 in 3
experiments; Fig. 3B,C). Rescue experiments with all-trans retinoic
acid (ATRA) were performed to determine if the effect of RALDH2
MOs was speciﬁc. We found that 70% of the RALDH2 morphants
had less severe facial defects, and no clefts, when treated with
5 μM ATRA (n=10, in 2 experiments, Supplemental Fig. 1IA–D). It
should be noted that a full rescue of all facial phenotypes would
not be expected since ATRA exposure was only during the time
when we believed that decreased RALDH2 affects upper lip and pri-
mary palate development.
We next examined the orofacial phenotype in the transverse sec-
tion and found that the oral cavity epithelium, labeled by e-cadherin,lined the cleft while mesenchymal cells were reduced dorsal to the
cleft compared to the control. This suggests that the facial promi-
nence mesenchyme did not converge or grow to populate the region
dorsal to the mouth (Fig. 3D,E).
While the above experiments were suggestive that RALDH2 is im-
portant for orofacial formation, it is also possible that the defects were
secondary to abnormalities caused either at an earlier time or to a
surrounding tissue. To further conﬁrm that RALDH2 was acting spe-
ciﬁcally in the orofacial tissue at the time of palate and upper lip de-
velopment, face transplants were performed to speciﬁcally localize
the morpholinos as described previously (Dickinson and Sive,
2009). The early mouth anlage and surrounding 1st branchial arch
from a morphant embryo (injected with ﬂuorescently labeled
RALDH2 or control morpholinos) were transplanted to the same loca-
tion in an un-injected sibling embryo at 24 hpf (Fig. 3F). The entire
dorsal extent of RALDH2 and RARγ expressing tissue could not be
transplanted since it caused defects to the developing brain in the
control embryos (not shown). Therefore, these experiments repre-
sent only partial loss of function. Despite this, face transplanted
RALDH2 morphants had an abnormally shaped mouth with an up-
ward indent or cleft in 80% of the embryos compared to controls
(n=10, 2 replicates, Fig. 3G,H). These results suggest that the oral
clefts created when there is decreased RALDH2 in whole embryos is
not simply due to earlier defects or abnormalities in surrounding tis-
sue. The converse experiment was also performed, in which the face
from an un-injected embryo was transplanted to the same location
in a RALDH2morphant (Fig. 3I). In this case, the mouth shape was im-
proved, having no cleft in 70% of morphants compared to un-
operated RALDH2 morphants (n=10, 2 replicates; Fig. 3J,K). Control
operated embryos were all normal. These results further conﬁrm
that RALDH2 is required speciﬁcally in the orofacial region, and that
loss of this protein results in a dorsal oral cleft-like defect.
Another method to inhibit RALDH2 function is to apply the
chemical, citral, to embryos (Cartry et al., 2006; Schuh et al., 1993).
When embryos were exposed to 100 μM citral (concentration
Fig. 3. A) Schematic showing experimental plan for B–E. B,C) Frontal view of tadpoles
at 4 dpf showing the embryonic mouth outlined in red dots. D,E) Transverse sections of
the orofacial region. E-cadherin labels the epithelium (red), counterstained with phal-
loidin (green). F) Schematic showing experimental plan for face transplants from mor-
phant to un-injected sibling. G,H) Frontal views of tadpoles showing the embryonic
mouth outlined in red dots 2 days after transplant procedure. I) Schematic showing ex-
perimental plan for face transplants from un-injected to morphant sibling. J,K) Frontal
views of tadpoles showing the embryonic mouth outlined in red dots 2 days after
transplant procedure. Abbreviations: cg; cement gland.
Fig. 4. A) Schematic showing experimental plan for B–I. B,C) Frontal view of tadpoles at
4 dpf showing the shape of the embryonic mouth (dotted in red). D,E) Transverse sec-
tions of the orofacial region. E-cadherin labels the epithelium (green), counterstained
with propidium iodide (red). F–G) In situ hybridizations for the neural crest marker
AP-2 (blue). F,H) Frontal views. G,I) Lateral views. The arrow points to the stomodeum
or oral cavity. Abbreviations: cg; cement. PI; propidium iodide, e-cad; e-cadherin, mhb;
midbrain–hindbrain boundary.
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24–30 (26–35 hpf), an orofacial cleft was apparent in 83% of the
embryos when compared to the controls (n=12, 2 replicates; Sup-
plemental Fig. 1IIII,J).Decreased RAR function also results in a median orofacial cleft
Since we found RARγ to be expressed in a complementary and
overlapping pattern with RALDH2 in the orofacial region, we hypoth-
esized that RARγ is a major receptor for retinoic acid in the orofacial
region. Therefore, we used a well characterized RAR pharmacological
inhibitor (BMS-453) (Cartry et al., 2006; Chen et al., 2004; Huang
et al., 2011). This inhibitor principally targets RARγ, and to a lesser
extent RAR α and β. Since the latter two are not expressed in the
orofacial region during the time frame examined, this inhibitor is
assumed to primarily target RARγ in our studies.
Tadpoles at stages 24 to 30 (26–35 hpf) were treated with BMS-
453 when RARγ is expressed in the facial prominences during early
orofacial development (Fig. 4A). At concentrations ranging from
0.5 μM to 10 μM an obvious median cleft was observed in 100% of
the treated tadpoles (10 μM shown, Fig. 4B,C). This defect was
highlighted when the region was sectioned transversely and labeled
for e-cadherin (an epithelial marker). The cleft was lined with epithe-
lium and the palatal region dorsal to the oral cavity was deﬁcient in
mesenchymal cells when compared to controls (Fig. 4D,E). All-trans
retinoic acid (ATRA; 5 μM) applied at the same time as 0.5 μM of
BMS-453 partially reduced the BMS-453 induced phenotype, and
the cleft was no longer evident (Supplemental Fig. 1IIE–H). These
results are consistent with ATRA rescue of BMS-453 induced abnor-
malities in other organs (Cartry et al., 2006; Chen et al., 2004).
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tadpoles treated with the RAR inhibitor is that neural crest speciﬁca-
tion or migration is perturbed. However, the treatment time partially
eliminates this possibility since we exposed embryos to the inhibitor
after the neural crest initiates migration into the cranial region. Fur-
ther, we examined a neural crest marker, AP-2 (de Croze et al., 2011)
at the end of treatment and observed no obvious difference in ex-
pression patterns in BMS-453 treated tadpoles compared to the con-
trol group (Fig. 4F–I). These results are consistent with experiments
in mice where ablation of RARγ/β in the cranial neural crest cell lin-
eage did not affect neural crest migration and speciﬁcation (Dupe
and Pellerin, 2009). Signiﬁcantly, such mutant mice were also
reported to have a dorsal median cleft that closely resembles the
cleft we observe in Xenopus.
We also asked whether RAR inhibitor treatment directly affected
apoptosis or cell division. We examined a mitotic marker (phospho-
histone H3; pH3) and apoptotic marker (cleaved caspase-3) at the
end of the treatment. No obvious differences were noted in the num-
ber of mitotic and apoptotic cells in the maxillary, nasal and frontona-
sal prominences (Supplemental Fig. 2A–I). These results suggest that
BMS-453 is not directly affecting cell proliferation or apoptosis at the
time of treatment, and is thus unlikely to be toxic. Additionally, the
brain and nasal placodes have been shown to be major signaling cen-
ters for the development of the orofacial region (Song et al., 2004).
Therefore, defects in either of these structures may secondarily affect
development of the upper lip and primary palate. However, upon
examination of the neural structures after BMS-453 treatment, we
did not see gross morphological defects in the brain and nasal pit
using tubulin as a marker (Supplemental Fig. 3A–B).
Loss of RAR function results in decreased transcriptional levels of the
homeobox genes lhx8 and msx2
To uncover the mechanism by which retinoic acid signaling results
in facial clefting, we examined changes in transcriptional levels of
genes after loss of RARγ function. Brieﬂy, embryos were treated
with 10 μM BMS-453 as described above. At the end of the treatment
the orofacial region was dissected, RNA extracted and microarray ex-
pression proﬁle performed (data not shown). Our preliminary results
revealed that the transcriptional levels of two homeobox genes,msx2Fig. 5. A–F) Frontal views of whole mount in situ hybridizations for lhx8 and msx2, (mRNA
plan H. H) RT-PCR using lhx8, msx2 and actin speciﬁc primers for control and RAR inhibitorand lhx8, were downregulated by RAR inhibitor treatment. We ﬁrst
characterized the expression of these genes by in situ hybridization
in normal developing embryos at a time when the RAR inhibitor
was applied at stages 28–30 (32–35 h). We observed that lhx8 was
expressed in bilaterally paired regions in the dorsal portion of the
ﬁrst branchial arch; a region that corresponds to the maxillary and
medial nasal prominences (Fig. 5A). Additionally, lhx8 was expressed
in paired regions of the ventral/anterior base of the telencephalon. At
the same stage, msx2 was expressed in a similar but smaller region in
the maxillary and/or medial nasal prominences compared to lhx8
(Fig. 5B).msx2was also expressed in a ventral and slightly more pos-
terior region at the base of the cement gland corresponding to a bmp4
expressing domain in the mandibular prominences (Bowes et al.,
2011). At stages 35–37 (50 hpf), lhx8 expression was similar to the
earlier time (Fig. 5C) while msx2 expression seemed to increase in
area in the maxillary and/or medial nasal prominences (Fig. 5D). In
summary, both lhx8 and msx2 share overlapping expression with
RARγ in the maxillary and nasal prominences (see Fig. 9A) suggesting
the possibility that these genes are indeed regulated by retinoic acid
signaling. We tested this hypothesis further by examining lhx8 and
msx2 expressions after RAR inhibitor treatment. In-situ hybridization
of the two genes revealed a more diffuse expression pattern in the re-
gion of the maxillary and nasal prominences (Fig. 5C–F). RT-PCR
revealed that both lhx8 and msx2 appeared downregulated in treated
embryos conﬁrming the preliminary microarray results (Fig. 5G,H).
Taken together these experiments conﬁrmed our hypothesis that
retinoic acid signaling regulates lhx8 and msx2 expressions.Combined loss of Msx2 and Lhx8 function results in a facial cleft
mimicking inhibition of retinoic acid signaling
If retinoic acid signaling regulates Lhx8 and Msx2 then we would
expect that loss of function of these homeobox genes would mimic
decreased RALDH2 or RARγ. Downregulation of Lhx8 using 90 ng of
a translation blocking MO resulted in a narrower face and close set
eyes. Further, 15% of these lhx8morphants had a subtle dorsal median
cleft in the oral cavity (Supplemental Fig. 4A,B; n=71, 2 experi-
ments). Since this was the ﬁrst time this lhx8 MO has been tested
we performed a rescue experiment to ensure its speciﬁcity. Lowin blue). The arrow points to the stomodeum. G) Schematic showing the experimental
treated tadpoles. Abbreviations: cg; cement.
Fig. 6. A) Schematic showing experimental plan for B–E. B,C) Frontal view of tadpoles
at 4 dpf showing the embryonic mouth outlined in red dots. D,E) Transverse sections of
the orofacial region. E-cadherin labels the epithelium (red), counterstained with phal-
loidin (green). F) Schematic showing experimental plan to determine synergy of RAR
inhibition and Lhx8/Msx2 loss of function. G–I) Frontal views of tadpoles showing
the embryonic mouth outlined in red dots, 2 days after RAR treatment. Abbreviations:
cg; cement.
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injected with 90 ng of lhx8MO. We found that lhx8 RNA resulted in a
62% complete rescue and 38% partial rescue of the lhx8 morphant
phenotype, where even the partially rescued tadpoles did not have
an orofacial cleft (n=84 in 2 experiments, Supplemental Fig. 4G–J).
Using up to 90 g of a validated msx2 splice blocking MO (Khadka
et al., 2006) did not result in a median cleft. In fact only 20% of
these msx2 morphants had a slightly malformed mouth opening
(Supplemental Fig. 4C; n=91, 2 experiments). Double lhx8/msx2morphants had a more profound phenotype with 63% of embryos
exhibiting dorsal median clefts at lower concentrations than either
lhx8 or msx2 morpholino alone (34 ng of each Lhx8MO and
Msx2MO; n=121, 2 experiments; Supplemental Fig. 4A–D). In trans-
verse sections of the lhx8/msx2 double morphants we observed that
the clefts were an extension of the oral epithelium, and there
were decreased mesenchymal tissues between the oral cavity and
brain (Fig. 6D–E). These clefts did indeed appear similar to those ob-
served in RALDH2 morphants and RAR inhibitor (BMS-453) treated
embryos as predicted (compare Figs. 3C,E, 4C,E to 6C,E). To further
test that Lhx8 and Msx2 are regulated by retinoic acid signaling,
we examined whether double lhx8/msx2 morphant phenotypes
were signiﬁcantly enhanced by the additional treatment of the
RAR inhibitor. Embryos were injected with low levels of lhx8/msx2
MOs (17 ng of each) and then treated with low levels of BMS-453
(0.1 μM) at stage 24 (26 hpf). In either treatment alone a phenotype
was not detected or very mild (n=20/treatment in 2 experiments).
However, when the lhx8/msx2 double morphants were also treated
with the RAR inhibitor; 60% of the resulting embryos had a dorsal
median cleft (Fig. 6F–J, n=20, 2 experiments). These results suggest
a synergistic effect between the RAR inhibitor and lhx8/msx2 mor-
pholinos. Therefore RAR, Lhx8 and Msx2 may exist within the
same functional pathway.Decreased retinoic acid signaling and Msx2/Lhx8 function results in
fewer proliferating cells in the developing maxillary, nasal and
frontonasal prominences
While we observed that there was no obvious change in cell divi-
sion or apoptosis directly after RAR inhibitor treatment, we noticed
that later in development the face became narrower (see Figs. 3B,C
and 4B,C). Loss of Msx2 and Lhx8 function also resulted in a similar
phenotype (see Fig. 6B,C). One possibility to explain this narrowing
face phenotype is that there is decreased growth of the orofacial tis-
sue due to later defects in cell division and/or cell survival. We ex-
amined markers for cell division (phospho-histone H3) and
apoptosis (cleaved caspase-3) at stages 37–40 when face narrowing
could ﬁrst be detected after RAR inhibitor treatment. Results indicat-
ed that treated embryos had 56% less mitotic cells in the region of
the maxillary and frontonasal prominences compared to the controls
(Fig. 7A,B; Student t-test, p=0.00013, compare outside the dotted
regions). A more severe effect on cell division was observed in
lhx8/msx2 double morphants (Fig. 7C,D). However, no obvious
change in cleaved caspase-3 immunohistochemistry was observed
in the facial prominences of either RAR inhibitor treated or lhx8/
msx2 double morphants, suggesting that cell death did not increase
(Supplemental Fig. 5A,B). Thus, a possible mechanism to explain
the narrow face and median cleft phenotype is that retinoic acid sig-
naling via Lhx8 and Msx2 is required for tissue growth of the dorsal
facial prominences.
To determine if cell cycle regulation was the primary reason for fa-
cial clefting we attempted to decrease cell division rates at stages
when we observed facial thinning after RAR inhibitor treatments.
We used a published method of inhibition of cell cycle in Xenopus,
using a combination of hydroxyurea and aphidicolin (HU/A) in a
bath application. Embryos were treated with HU/A at three different
concentrations (150 μM/20 μM, 300 μM/20 μm and 75 μM/10 μM) at
two different time periods (stages 26 to 31 or 32 to 41). While all
treated embryos had malformed faces, we did not observe dorsal me-
dian clefts with any treatment (Supplemental Fig. 6, n=10 per treat-
ment, 2 replicates for each treatment). These results suggest that
decreased proliferation alone does not induce dorsal facial clefts,
and does not account for the entire RAR inhibitor and lhx8/msx2mor-
phant phenotype. However, it is possible that decreased proliferation
contributes to the cleft phenotype. Therefore, it might be expected
Fig. 7. A–D) Transverse sections through the dorsal facial prominences showing
phospho-histone H3 immunohistochemistry (pH3; green) counterstained with propi-
dium iodide (red). The brain and nasal pits are outlined in white dots. pH3 positive
cells were counted in the region below the white dots. E) Schematic showing experi-
mental plan for F–I. F–I) Frontal views of tadpoles at 4 dpf showing the embryonic
mouth outlined in red dots. Abbreviations: cg = cement.
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tenuate the phenotype resulting from RAR inhibition. Therefore, we
examined the effect of a cell cycle checkpoint inhibitor, wee-1,
(Palmer et al., 2006) on the phenotype created by the RAR inhibitor
(Fig. 7E). We observed that together, 10 μM of the wee-1 inhibitor
and 1 μM of the RAR inhibitor resulted in embryos with a severely
malformed face. However, the median cleft in these combined wee-
1 and RAR inhibitor treated tadpoles appeared to be less sharp than
that of the RAR inhibitor alone (Fig. 7F–I; 70%, n=10, 2 experiments).
These results suggest that decreased cell cycle may contribute partial-
ly to the median cleft phenotype observed after decreased RAR and
Lhx8/Msx2 function.
Decreased retinoic acid signaling and Msx2/Lhx8 function results in
defects in the formation of the dorso-anterior cartilage
Since we observed that RALDH2 andmsx2/lhx8morphants, as well
as tadpoles treated with the RAR inhibitor, had narrower faces and
decreased cell proliferation in the dorsal facial prominences; weasked whether this resulted in later defects in the facial jaw cartilage.
We examined cartilage by performing Alcian blue staining. RAR inhib-
itor treated embryos were missing dorso-anterior cartilages that con-
tribute to the palate and upper lip. Speciﬁcally, the ethmoid plate,
palatoquadrate, suprarostral and trabeculum cartilages were smaller
or absent (Fig. 8A–D). The cartilages were more severely affected in
msx2/lhx8 double morphants, likely owing to the loss of these genes
at earlier stages and their possible additional roles in early neural
crest development (Khadka et al., 2006). The cartilages also most de-
formed were the anterior-dorsal cartilages, many of which could not
be identiﬁed (Fig. 8E–H).
We next asked whether the cartilage forming chondrocytes differ-
entiated in the primary palate region using collagen II protein as a
marker. We did not observe collagen II protein in the dorso-anterior
region in the RAR inhibitor treated embryos or lhx8/msx2 double mor-
phants as it was in the controls (Fig. 8I–L). These results suggest that
the cells forming cartilage do not form in the region fated to become
the upper lip and primary palate when embryos are depleted of reti-
noic acid signaling or Lhx8/Msx2 function. It is possible that not
enough cells are generated, or that retinoic acid via Lhx8/Msx2 is
also required for differentiation of the chondrocytes.
Discussion
Craniofacial development requires complex interactions between
the epithelium, endoderm, mesoderm and cranial neural crest. Reti-
noic acid has been shown to affect such interactions at a number of
different times and locations during the development of the pharyn-
geal arches and facial prominences (Abe et al., 2008; Bothe et al.,
2011; Brickell and Thorogood, 1997; Kopinke et al., 2006; Mark
et al., 2004; Mendelsohn et al., 1994; Niederreither et al., 2003). In
the present study, we show that retinoic acid is required for yet
another aspect of orofacial development: formation of the upper lip
and primary palate in X. laevis. Based on the results presented we pro-
pose a model whereby retinoic acid regulates expression of homeo-
box genes msx2 and lhx8, which in turn are responsible for tissue
growth and differentiation of the facial prominences required for
upper lip and primary palate development.
Median clefting and facial hypoplasia in vertebrates
Median facial hypoplasia, or median cleft lip and primary palate,
are often attributed to deﬁciency or agenesis in midface development
(Allam et al., 2011). The phenotype ranges from severe defects in all
median structures including the forebrain and nasal structures, to
less severe defects such as a median cleft in the upper lip and primary
palate. Such anomalies are seen in multiple craniofacial affected dis-
orders such as Binder, Antley–Bixler, Crouzon, and fetal alcohol syn-
dromes (Adolphs et al., 2011; Defraia et al., 2011; Johnson et al.,
1996; Snyder-Warwick et al., 2010). Clefts in the upper lip and pri-
mary palate have also been proposed to be an underlying cause of
the more common clefts of the secondary palate (Jiang et al., 2006).
While little is known about the genetic or environmental causes of
median facial clefts, human cases of median orofacial clefts have been
associated with retinoic acid and vitamin D deﬁciencies, as well as
genetic mutations in Fgf receptors, Alx gene family members and
the Six2 transcription factor (Beverdam et al., 2001; Fogelgren et al.,
2008; Snyder-Warwick et al., 2010; Twigg et al., 2009). A literature
review also uncovered other affected genes in vertebrates displaying
median clefts such as PDGF, kif3a, gli3, lhx8 and msx2 (Brugmann
et al., 2010; Eberhart et al., 2008; Winograd et al., 1997; Zaghloul
and Brugmann, 2011; Zhao et al., 1999). Genetically or mechanisti-
cally, it has been unclear whether there are any connections between
these genes during upper lip and palate development. Therefore, our
goal was to begin to make inroads into further understanding the
molecular mechanisms that underlie the development of the upper
Fig. 8. A–H) Alcian blue staining showing cartilage in 4–5 dpf tadpoles. Top row shows the ventral views and the second row shows the dorsal views. I–N) Transverse sections at 3–
4 dpf through the primary palate region. Collagen II immunohistochemistry (green) counterstained with propidium iodide (red). Abbreviations, sr; suprarostral, qua; quadrate, ir;
infrarostral, Mk; Meckel's, ch; ceratohyal, bh; basihyal, eth; ethmoid, trab; trabecular, pq; palatoquadrate, np; nasal pit, oc; oral cavity.
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as a possible major regulator of the dorsal orofacial region.Retinoic acid signaling is required for upper lip and primary
palate formation
Retinoic acid is well known for its role in craniofacial develop-
ment, however little attention has been paid to its possible role in
the formation of the upper lip and primary palate. In this study,
we show that loss of retinoic acid signaling results in a median facial
cleft in X. laevis. We also found that such median clefts are accompa-
nied by defects in dorso-anterior cartilaginous structures. Speciﬁcal-
ly, we noted a loss of the ethmoid (which supports the base of the
nasal cavity), the suprarostral plate (which supports the upper lip)
and the palatoquadrate (which forms the posterior roof of the oral
cavity). Similarly, a median cleft was also reported in RARα/RARγ
mutant mice (Dupe and Pellerin, 2009; Lohnes et al., 1994) and
mice deﬁcient for endogenous retinoic acid synthesis (P. Dollé,
unpublished observations). Associated skeletal defects in the RARα/
RARγ mutants also included dorso-anterior cartilages and bones
such as the frontal and nasal bones, the medial rostral cranial base
and the ethmoid cartilage (Lohnes et al., 1994). Together, these re-
sults suggest that the role for retinoic acid signaling in forming the
upper lip and primary palate is conserved across vertebrates.
When retinoic acid signaling is disrupted, the palate and upper
lip associated structures affected are the neural crest derivatives.
Therefore, it might be reasonable, then, to speculate that retinoic
acid deﬁciency affects the speciﬁcation and/or migration of the neu-
ral crest. However, we and others have uncovered that retinoid-
induced defects occur without any obvious alteration of the neural
crest speciﬁcation, migration or apoptosis (Gitton et al., 2010;
Lohnes et al., 1994). Further, it might also be postulated that median
orofacial clefts are simply a side effect of defects in the formation of
the brain and nasal placodes, which serve as major signaling centers
for the face. However, we did not note any major abnormalities in
the early formation of the brain or nasal pits in tadpoles treated
with the retinoic acid inhibitor. Similarly, RARα/RARγ mutant mice
had no defects in early brain development (Lohnes et al., 1994).
Thus, retinoic acid signaling more likely targets receptors in neural
crest and/or mesoderm cells at the time of facial prominence devel-
opment and differentiation.Retinoic acid signaling regulates expression of homeobox genes msx2
and lhx8
It has been well established that retinoic acid signaling regulates
hox gene expression in the brain (reviewed in Glover et al., 2006).
Therefore, it was reasonable to speculate that retinoic acid may reg-
ulate similar homeodomain containing genes in the facial region.
We found that retinoic acid indeed regulates two homeobox
genes, msx2 and lhx8. Both genes have been shown to have impor-
tant roles in craniofacial development, and loss of function of
these genes also results in median clefts in mice (Alappat et al.,
2003; Winograd et al., 1997; Zhao et al., 1999). After RAR inhibitor
treatment we observed decreased expression and a diffuse pattern
of both msx2 and lhx8 in the orofacial region. Further, a synergistic
effect was observed in tadpoles where RAR was inhibited and
Msx2/Lhx8 were decreased, suggesting that these genes act in the
same functional pathway. In support of these ﬁndings, it has also
been reported that msx2 expression in the facial prominences is
altered in response to changes in retinoic acid signaling in both
mice and chick (Brown et al., 1997; Song et al., 2004; Washbourne
and Cox, 2006). We are the ﬁrst to also report a connection between
retinoic signaling and lhx8 expression.
It is possible that retinoic acid signaling regulates msx2 and lhx8
expressions directly. In support of this hypothesis, retinoic acid re-
sponse elements (RARE domains) have been reportedly located 3′
and/or 5′ to the coding region of msx2 (reviewed in Alappat et al.,
2003; Glover et al., 2006). Further, examination of a 10 kB upstream
region of both genes in Xenopus tropicalis indicates several RAR con-
sensus binding sites (Transcription Element Search System, TESS)
also suggesting possible direct regulation by retinoic acid signaling.
Future ChiP studies await effective Xenopus RAR antibodies to deter-
mine if retinoic acid regulatesmsx2 and lhx8 directly in the formation
of the upper lip and palate.
An alternative to direct activation is that retinoic acid signaling
regulates Lhx8 and Msx2 indirectly by activating intermediate path-
ways. Such intermediate pathways may be bone morphogenetic pro-
tein (BMP) and ﬁbroblast growth factor (FGF). Retinoic acid
signaling has been implicated in regulating both of these signaling
pathways during craniofacial development (Abe et al., 2008; Song
et al., 2004). Further, BMP has in turn been shown to control Msx
gene family expression in mice and chick (reviewed in Greene and
Pisano, 2010; Jugessur et al., 2009). There is also evidence that Fgf
Fig. 9.Model of the experimental results. A) Frontal view of a representative embryo at stage 30 (35 hpf) showing expression domains of RALDH2, RARγ, lhx8 and msx2 overlaid
onto the prospective facial prominences. B) A simple model of how retinoic acid and lhx8/msx2 regulate growth and differentiation of the prominences that contribute to the
upper lip and primary palate. C) Decreased retinoic acid signaling results in decreased Lhx8 and Msx2 function. This in turn results in decreased growth and differentiation of
the prominences that contribute to the upper lip and primary palate contributing to the formation of a median cleft. Abbreviations: mx; maxillary prominence, mnp; medial
nasal prominence, ma; mandibular prominence, op; olfactory placode or pit.
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et al., 2006). Such integration of signaling pathways would explain
why perturbing BMP, FGF and retinoic acid can have similar effects
on facial development.
Retinoic acid signaling and Msx2/Lhx8 function to regulate cell
proliferation and differentiation in the dorso-anterior facial prominences
In our studies, RAR inhibition produced embryos with a median
facial cleft associated with a narrower face and decreased cell prolif-
eration. Additionally, msx2/lhx8 double morphants also displayed a
median cleft associated with severe facial hypoplasia and decreased
cell division. These results lead us to formulate the hypothesis that
retinoic acid signaling via Lhx8 and Msx2 regulates proliferation in
the orofacial region. Indeed, we did ﬁnd a signiﬁcant decrease in mi-
totic cells in lhx8/msx2 morphants and embryos treated with the
RAR inhibitor, suggesting that this was a factor in the median cleft-
ing phenotype. Additionally, we could partially rescue the clefting
phenotype induced by RAR inhibition with a cell cycle checkpoint in-
hibitor. However, we did not ﬁnd that inhibition of cell cycle alone
could illicit a facial cleft, suggesting that retinoic acid signaling
may be responsible for other mechanisms such as differentiation
and cell movements required for upper lip and palate development.
A role for retinoic acid, Lhx8 and Msx2 in regulating cell cycle is a
plausible hypothesis based on a previous work. In fact, it has been
suggested that a common mechanism of many teratogens that result
in facial clefts, including retinoic acid, could be disruption of the cell
cycle (Dhulipala et al., 2006). Further, many homeobox proteins tar-
get cell cycle genes regulating tissue growth of various organs (Del
Bene and Wittbrodt, 2005). Msx and Lhx gene families, speciﬁcally,
have been shown to regulate cell cycle during development. For ex-
ample, one function of Msx2 is to maintain the facial mesenchyme
in a proliferative undifferentiated state (Ishii et al., 2003). Dodig
et al. (1999) also showed that overexpression of Msx2 increases cell
division in the palate, while loss of function has the opposite effect.
Msx1 and 2 have also been reported to regulate cyclin D expression
and thus control cell cycle progression directly (Hu et al., 2001).
While Lhx genes have been more widely shown to regulate cell fate,
(reviewed in Zheng and Zhao, 2007) some Lhx family members
have also been shown to regulate cell proliferation. For example,
Lhx2 regulates neural precursor proliferation in the forebrain
(Porter et al., 1997). On the other hand, it is also possible that Lhx8
and/or Msx2 modulate differentiation of chondrocytes that form car-
tilage elements of the upper lip and primary palate development. Lhx
gene family members have been shown to be part of the transcrip-
tional networks which regulate odontogenic fates in mammalian
dentition (Denaxa et al., 2009), as well as pituitary speciﬁc cell fates
(Colvin et al., 2009; Mullen et al., 2007). The idea that Lhx8 and/or
Msx2may also regulate differentiation would explain why perturbingcell cycle alone does not fully mimic the loss of Lhx8 and Msx2 or reti-
noic acid signaling. This would also explain the lack of collagen II pro-
tein (a marker for differentiating chondrocytes) that forms in the
primary palate region. Thus, our results suggest a possible dual role
for Lhx8 and Msx2 in regulating both proliferation and differentiation
and these two processes together are necessary for the development
of the upper lip and primary palate.Summary and conclusions
Our data brings together a model to explain the mechanism by
which median facial clefts form in vertebrates. We propose that reti-
noic acid synthesized in the cells of the nasal prominences and sto-
modeum diffuses and binds to RARγ receptors in the mesenchymal
cells of the maxillary and median nasal prominences (Fig. 9A). RARγ
either directly or indirectly activates transcription of the homeobox
genes lhx8 and msx2. These genes in turn regulate proliferation and
differentiation necessary for the growth and convergence of the facial
prominences during palate and upper lip development (Fig. 9B,C).
Loss of retinoic acid, or both lhx8 and msx2, results in deﬁcient tissue
growth and differentiation so that the convergence and later fusion of
the maxillary and nasal prominences with the frontonasal promi-
nence does not occur. This leaves a large median gap in the upper
lip and primary palate.
In conclusion, the complexity of palate morphogenesis is matched
by an equally complex network of signaling molecules that include
BMP, FGF, Wnt and SHH (Brugmann et al., 2006; Brugmann et al.,
2007; Greene and Pisano, 2010; Jiang et al., 2006; Liu et al., 2010;
Tapadia et al., 2005). We have found that retinoic acid is also a critical
player in this network of upper lip and primary palate regulators. We
are currently performing a more extensive gene expression analysis
to better understand how retinoic acid signaling interfaces with
these other signaling pathways. Our work has the potential to better
understand the complex nature of orofacial development which will
lead to important insights into the etiology of human orofacial clefts.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ydbio.2012.02.033.References
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